Literature DB >> 16480669

Tissue print micropeel: a new technique for mapping tumor invasion in prostate cancer.

Sandra M Gaston1, Melissa P Upton.   

Abstract

Because of widely adopted screening programs for early detection of prostate cancers, many patients who undergo radical prostatectomy have tumors that are not grossly evident, and the extent and distribution of the cancer in the gland can only be determined by a microscopic examination of the surgical specimen. Historically, one of the most important predictors of the quality of cancer control following surgical resection of a solid tumor is the absence of cancer at the surgical margins. Although the clinical significance of cancer at the margins of a radical prostatectomy specimen has been a source of controversy in recent years, surgical pathology assessment of radical prostatectomy margins remains an important part of prostate cancer clinical care. However, a comprehensive histopathologic review of every radical prostatectomy specimen is beyond the resources of most hospitals. Tissue print micropeel technologies, combined with appropriate markers, provide a new strategy that combines a relatively simple technique for sampling specimen margins with a method for obtaining molecular information about the cancer that can add to the macroscopic and microscopic anatomical findings. This new tissue printing approach for incorporating molecular markers into the assessment of radical prostatectomy margins is reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480669     DOI: 10.1007/s11934-006-0038-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  40 in total

Review 1.  Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Authors:  D G Bostwick; D J Grignon; M E Hammond; M B Amin; M Cohen; D Crawford; M Gospadarowicz; R S Kaplan; D S Miller; R Montironi; T F Pajak; A Pollack; J R Srigley; J W Yarbro
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 2.  Emerging issues of the expression profiling technologies for the study of gynecologic cancer.

Authors:  Kalliopi I Pappa; Nicholas P Anagnou
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 3.  In silico analysis of angiogenesis associated gene expression identifies angiogenic stage related profiles.

Authors:  Judy R van Beijnum; Arjan W Griffioen
Journal:  Biochim Biophys Acta       Date:  2005-07-25

4.  The influence of extent of surgical margin positivity on prostate specific antigen recurrence.

Authors:  R E Emerson; M O Koch; T D Jones; J K Daggy; B E Juliar; L Cheng
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 5.  Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.

Authors:  Gry Sjøholt; Nina Anensen; Line Wergeland; Emmet Mc Cormack; Øystein Bruserud; Bjørn Tore Gjertsen
Journal:  Curr Drug Targets       Date:  2005-09       Impact factor: 3.465

6.  Cancer control with radical prostatectomy alone in 1,000 consecutive patients.

Authors:  Gerald W Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

7.  Prostate tumor progression and prognosis. interplay of tumor and host factors.

Authors: 
Journal:  Urol Oncol       Date:  2000-11-01       Impact factor: 3.498

8.  Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression.

Authors:  Hakan Aydin; Toyonori Tsuzuki; David Hernandez; Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Journal:  Urology       Date:  2004-09       Impact factor: 2.649

9.  Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.

Authors:  Viola M M van Houten; C René Leemans; J Alain Kummer; Janny Dijkstra; Dirk J Kuik; Michiel W M van den Brekel; Gordon B Snow; Ruud H Brakenhoff
Journal:  Clin Cancer Res       Date:  2004-06-01       Impact factor: 12.531

Review 10.  Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy.

Authors:  Kristen M Carr; Kevin Rosenblatt; Emanuel F Petricoin; Lance A Liotta
Journal:  Hum Genomics       Date:  2004-01       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.